OnQuality Announces FDA Clearance of IND Application for OQL051
Newsroom




- Apr 28
OnQuality Announces FDA Clearance of IND Application for OQL036


- Apr 18
OnQuality Pharmaceuticals Presented Preclinical Data at the AACR Annual meeting


- Mar 15
OnQuality Pharmaceuticals Announces Presentations of OQL025 and OQL06x, at the AACR Annual Meeting


- Jan 5
OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India


- Nov 10, 2022
Targeted Oncology First Patient With VEGFRi-Associated Hand-Foot Skin Reaction Enrolled in NOVA-II

- Nov 9, 2022
Clinical Trials Arena I OnQuality enrols first subject in Phase II HFSR therapy trial


- Nov 8, 2022
OnQuality Pharmaceuticals Announces Enrollment of First Patient in Part 2 of the NOVA-II Phase 2


- Oct 14, 2022
OnQuality Pharmaceuticals to Present Two Posters at the 34th EORTC-NCI-AACR Symposium


- Aug 3, 2022
Behind Biotech I Hong Tang on Traditional Chinese Medicine and Targeted Cancer Supportive Therapy